LobbyingMonoamine Oxidase Deficiency Foundation lobbying by quarter
Monoamine Oxidase Deficiency Foundation's latest lobbying report covers Q3 2025, at $21.5K. Its first report covers Q2 2024.
Monoamine Oxidase Deficiency Foundation
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q2 2024
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2024 | $21.5K | 1 |
| Q3 2024 | $21.5K | 1 |
| Q4 2024 | $21.5K | 1 |
| Q1 2025 | $21.5K | 1 |
| Q2 2025 | $21.5K | 1 |
| Q3 2025 | $21.5K | 1 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
No issue reported.
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
No house or agency named.
Firms it paid
| Firm | ||
|---|---|---|
| Ellis & Company | $129K | 6 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 06/29for Q3 2025 | Ellis & Company | $21.5K |
| 06/29for Q2 2025 | Ellis & Company | $21.5K |
| 06/29for Q1 2025 | Ellis & Company | $21.5K |
| 06/29for Q4 2024 | Ellis & Company | $21.5K |
| 06/29for Q3 2024 | Ellis & Company | $21.5K |
| 06/29for Q2 2024 | Ellis & Company | $21.5K |